Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects
Clinical trial NCT03087942 · COMPLETED
Trial details
- NCT number
- NCT03087942
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2018-08-07
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.